---
title: "Endovascular Engineering’s ENGULF pivotal trial completes patient enrolment"
date: "2025-06-25T13:42:31.000Z"
publishedDate: "25 juin 2025"
summary: "Endovascular Engineering (E2) has completed patient enrolment in the pivotal cohort of its ENGULF trial, involving the Hēlo pulmonary embolism (PE) thrombectomy system. The investigational device exemption study was carried out at 19 interventional cardiology, radiology, and vascular surgery centres in the USA."
importance: ""
sourceUrl: "https://vascularnews.com/endovascular-engineerings-engulf-pivotal-trial-completes-patient-enrolment/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-06-25-endovascular-engineerings-engulf-pivotal-trial-completes-patient-enrolment"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/06/Endovascular-Engineering-logo-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/endovascular-engineerings-engulf-pivotal-trial-completes-patient-enrolment/"
---

![Endovascular Engineering’s ENGULF pivotal trial completes patient enrolment](https://vascularnews.com/wp-content/uploads/sites/7/2025/06/Endovascular-Engineering-logo-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/endovascular-engineerings-engulf-pivotal-trial-completes-patient-enrolment/*

## L’essentiel

Endovascular Engineering (E2) has completed patient enrolment in the pivotal cohort of its ENGULF trial, involving the Hēlo pulmonary embolism (PE) thrombectomy system. The investigational device exemption study was carried out at 19 interventional cardiology, radiology, and vascular surgery centres in the USA.

## Lien source

https://vascularnews.com/endovascular-engineerings-engulf-pivotal-trial-completes-patient-enrolment/
